3 completed, 1 recruiting, 1 unknown. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 3, Recruiting 1, Unknown 1 |
Follow iloperidone: new trials by email Literature Review of iloperidone trials Research Report on iloperidone
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Randomized Withdrawal Study in Patients With Schizophrenia iloperidone, placebo - Schizophrenia | Phase 3 | Recruiting | Vanda Pharmaceuticals | 400 | 2025-05-14 | 2026-01-12 |
| Evaluation of Efficacy and Safety of Iloperidone in the Acute Treatment of Manic or Mixed Episodes Associated With Bipolar I Disorder Iloperidone, Iloperidone Placebo - Bipolar I Disorder | Phase 3 | Completed | Vanda Pharmaceuticals | 417 | 2021-03-22 | 2024-04-18 |
| Risperidone-controlled,Multicentre Clinical Trial of Iloperidone in Patients With Schizophrenia Iloperidone, Risperidone - Schizophrenia | Phase 3 | Unknown | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 288 | 2013-11-01 | 2015-05-27 |
| Relapse Prevention Study in Patients With Schizophrenia Iloperidone, Placebo - Schizophrenia | Phase 3 | Completed | Vanda Pharmaceuticals | 635 | 2011-02-01 | 2023-07-17 |
| Efficacy and Safety of Iloperidone Compared With Placebo and Active Control in Subjects With Acute Schizophrenia Iloperidone, Ziprasidone, Placebo - Schizophrenia | Phase 3 | Completed | Vanda Pharmaceuticals | 593 | 2005-11-18 | 2026-10-06 |
Schizophrenia (4) · Mental Disorders (1) · Psychotic Disorders (1)
Vanda Pharmaceuticals (4) · CSPC ZhongQi Pharmaceutical Technology Co., Ltd. (1)
United States (4) · India (2) · Bulgaria (1) · China (1) · Poland (1) · Ukraine (1)